Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuropsychobiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7969854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmunity in schizophrenia: a review of recent findings.

  1993cited by this paper
• Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions.

  1992cited by this paper
• Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations.

  1992cited by this paper
• Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.

  1991cited by this paper
• Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures.

  1991cited by this paper
• Serum interleukin-6 in schizophrenic patients.

  1991cited by this paper
• Cytokines: coordinators of immune and inflammatory responses.

  1990cited by this paper
• On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

  1989cited by this paper
• Elevated levels of soluble interleukin 2 receptors in schizophrenia.

  1989cited by this paper
• Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production.

  1989cited by this paper
• Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects.

  1989cited by this paper
• Decreased interleukin-2 production in schizophrenic patients.

  1989cited by this paper
• Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro.

  1988cited by this paper
• Interleukin-1 immunoreactive innervation of the human hypothalamus.

  1988cited by this paper
• Serum interferon in patients with psychosis.

  1985cited by this paper
• A rating scale for emotional blunting.

  1978cited by this paper

• Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines.

  2025cites this paper
• Evaluation of IL-1β, IL-6, and inflammatory markers during exacerbation and after antipsychotic treatment in drug-free schizophrenia patients

  2025cites this paper
• Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis

  2023cites this paper
• Evidence for Cytokine Dysregulation in Schizophrenia Spectrum Disorders: A Comparison of Cerebrospinal Fluid and Blood Samples

  2023cites this paper
• The role of non-neuronal cells in hypogonadotropic hypogonadism.

  2020cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies.

  2019cites this paper
• Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.

  2018cites this paper
• Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

  2018cites this paper
• Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression

  2018cites this paper
• Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?

  2017cites this paper
• Is it time for immunopsychiatry in psychotic disorders?

  2016cites this paper
• Cytokines in schizophrenia: methodological issues.

  2015cites this paper
• On neuroinflammation in psychotic disorders

  2014cites this paper
• Inflammatory cytokine network in schizophrenia

  2014cites this paper
• Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

  2013cites this paper
• Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

  2013cites this paper
• Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.

  2012cites this paper
• The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

  2012cites this paper
• Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

  2012cites this paper
• Sexual Differentiation of the Rodent Brain: Dogma and Beyond

  2012influential citation
• Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population

  2011cites this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cites this paper
• Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

  2008cites this paper
• Effects of Toxoplasma gondii infection on the brain.

  2007cites this paper
• Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta.

  2006cites this paper
• Cytokines in schizophrenia and the effects of antipsychotic drugs.

  2006cites this paper
• [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

  2004cites this paper
• Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype

  2003cites this paper
• Zytokinnetzwerke bei Patienten mit Schizophrenie und ihre Bedeutung für die Pathophysiologie der Erkrankung

  2003cites this paper
• The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms.

  2001cites this paper
• Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.

  2000cites this paper
• Elevated interleukin-6 in schizophrenia

  1999cites this paper
• Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

  1999cites this paper
• Plasma Interleukin-1 beta and Sleep Architecture in Schizophrenia and Other Nonaffective Psychoses

  1997cites this paper
• Transforming growth factors beta 1 and beta 2 in the cerebrospinal fluid of chronic schizophrenic patients.

  1997cites this paper